转换驱动因素:表观遗传重新连接到质瘤中的遗传进展
Kristen L Drucker1, Robert B Jenkins1, Daniel Schramek2,3
1Mayo Clinic, Rochester, Minnesota.
Cancer research
|January 9, 2025
概括
异酸脱酶 (IDH) 突变性质瘤通过表观遗传变化和寡基细胞前体细胞,然后通过遗传变化和神经前体细胞进展. 在这种恶性转变过程中,干扰素信号被动态调节.
科学领域:
- 神经瘤学神经瘤学
- 癌症生物学 癌症生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 具有IDH突变的低级质瘤往往会发展为具有不良预后的高级质瘤.
- 了解这种恶性进展的分子机制对于开发有效疗法至关重要.
研究的目的:
- 阐明IDH突变质瘤恶性进展的细胞和分子驱动因素.
- 为了研究干扰素信号的动态调节在质瘤等级的进步.
主要方法:
- 在不同级别的质瘤中进行单细胞基因表达分析.
- 染色体可访问性分析,以评估表观遗传变化.
- 对遗传变化的分析及其与瘤进展的相关性.
主要成果:
- 质瘤进展的两阶段模型:早期阶段由类细胞前体样细胞和瘤抑制剂的表观遗传沉默 (例如CDKN2A) 驱动,后期阶段由增殖的神经前体样细胞和遗传改变 (例如PDGFRA,MYCN放大,CDKN2A/B删除) 驱动.
- 干扰素 (IFN) 反应通过表观遗传高甲基化通过低度质瘤被抑制,通过IDH或DNA甲基转移酶1抑制剂可逆.
- 高度质瘤通过IFN基因的遗传删除来逃避IFN信号,这表明从表观遗传转向遗传调节.
结论:
- IDH突变质瘤的恶性进展涉及从表观遗传转向遗传瘤调节的转变.
- 动态调节的IFN信号传递,抑制表观遗传然后遗传,在质瘤的进展中发挥着关键作用.
- 这些发现为了解质瘤演变提供了一个框架,并建议针对表观遗传修饰和IFN通路的重新激活的治疗策略.
更多相关视频
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
13.4K
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
3.4K
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
